Healthcare Realty Trust closed out its Q2 earnings week with a 2.4% drop on Friday, but the bigger story is what short sellers did before and after the print — and what the analyst community did the morning results landed.
Cantor Fitzgerald moved first on earnings day, lifting its price target from $22 to $24 while holding its Overweight rating — a notable post-print endorsement with HR trading at $21.01. That puts the bull case at roughly 14% upside from current levels. The broader analyst community remains more cautious, with the consensus sitting at Hold and a cluster of neutrals from JP Morgan, UBS, Wells Fargo, and RBC all carrying targets in the $21 range — essentially flat with today's price. Raymond James is the other outlier with an Outperform reinstated in mid-June and a $24 target. The Street's direction of travel has been consistently upward on targets since May, even as ratings stay anchored at hold-equivalent. Bulls point to the company's position as the largest pure-play medical office REIT, with 36 million square feet and steady U.S. revenue generation. Bears flag NAV declines, occupancy headwinds, and underperformance versus peers as reasons to stay sidelined.
Short sellers have been voting with their feet — and the vote is to exit. SI has fallen 10.6% over the past week to 4.8% of the free float, extending a drawdown from a mid-July peak near 5.7% of float. The retreat continues a pattern visible since July 20, when the position was running closer to 5.7%. The borrow market remains emphatically loose: availability has actually widened further to 973%, meaning for every share currently borrowed there are nearly ten sitting unused in the lending pool. Cost to borrow ticked up modestly to 0.46% on the week, but at those levels it represents no friction for new shorts — and no squeeze pressure for existing ones. The ORTEX short score has also drifted lower, falling from 47 in mid-July to 42.4, consistent with the easing short thesis.
Options positioning did reflect the earnings caution flagged in Thursday's preview note — the put/call ratio spiked to 0.165 on July 31, nearly 2.4 standard deviations above its 20-day average of 0.079. That spike has now resolved post-print. What's notable is how quickly the defensive bid appeared and how absent it had been for most of July, when the PCR sat in a remarkably narrow 0.087–0.088 range for nearly three consecutive weeks. The earnings reaction itself came in at -3.7% on the day, which confirms the options hedgers were right to be cautious.
The institutional base is anchored. BlackRock holds 15.8% of shares, adding 1.2 million shares in the most recent quarter. T. Rowe Price added just over 1 million shares. Starboard Value holds a roughly 2% activist-adjacent position, unchanged last quarter. The combination of stable passive ownership and an active presence gives the shareholder base a different character from a typical small-cap REIT — there is institutional ballast here even as sentiment remains mixed.
Healthcare peers had a rough week across the board. WELL fell 7.0% and VTR shed 6.9%, while SBRA dropped 5.3% and LTC lost 4.6%. HR's 1.8% weekly decline was notably smaller than that peer group, suggesting the stock absorbed its own earnings disappointment with relative resilience — shorts covering into the print may have helped cushion the fall. The next earnings event is dated for October 30, which makes occupancy trends and asset-sale progress the data points worth tracking between now and then.
See the live data behind this article on ORTEX.
Open HR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
